IDXX - Company ID 0000874716
The table below shows IDEXX LABORATORIES INC /DE's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $180.07M | $288.27M | $453.93M | $112.55M | $144.45M | $383.93M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $552.38M | $473.57M | $457.44M | $400.62M | $368.35M | $331.43M |
| Inventory | $377.76M | $381.88M | $380.28M | $367.82M | $269.03M | $209.87M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.41B |
| $1.40B |
| $1.50B |
| $1.10B |
| $955.65M |
| $1.06B |
| Property, plant & equipment | $747.38M | $713.12M | $702.18M | $649.47M | $587.67M | $555.17M |
| Goodwill | $414.00M | $405.10M | $365.96M | $361.80M | $359.35M | $243.35M |
| Total assets | $3.35B | $3.29B | $3.26B | $2.75B | $2.44B | $2.29B |
| Accounts payable | $110.41M | $114.21M | $110.64M | $110.22M | $116.14M | $74.56M |
| Total current liabilities | $1.15B | $1.07B | $951.55M | $1.24B | $763.58M | $582.76M |
| Long-term debt | $374.84M | $449.79M | $622.88M | $694.39M | $775.21M | $858.49M |
| Total liabilities | $1.75B | $1.70B | $1.78B | $2.14B | $1.75B | $1.66B |
| Retained earnings | $6.39B | $5.33B | $4.44B | $3.60B | $2.92B | $2.18B |
| Total equity | $1.61B | $1.60B | $1.48B | $608.74M | $689.99M | $632.09M |